The United States Environmental Protection Agency has rescinded prior limits on carbon emissions from coal and gas power plants. This policy reversal, which will reportedly save billions of dollars, is presented by officials as a measure to reduce energy costs, prioritising economic considerations over environmental regulation.
Rybelsus, a daily oral medication by Novo Nordisk, is now available in the UK for private purchase. This drug, containing the active ingredient semaglutide, has received approval for treating type 2 diabetes and is prescribed off-label for weight management.
The European Union's new Entry/Exit System (EES), a digital border control, is set to introduce significant delays at UK airports for non-EU travellers this summer. The system, which requires fingerprint and facial scans, bypasses Schengen Zone passport stamps and is a direct consequence of the UK's departure from the EU.
